Clinical Pediatrics

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shohat, M.
Right arrow Articles by Varsano, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shohat, M.
Right arrow Articles by Varsano, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Pediatrics, Vol. 25, No. 4, 209-212 (1986)
DOI: 10.1177/000992288602500407

Adrenocortical Suppression by Topical Application of Glucocorticosteroids in Infants with Seborrheic Dermatitis

M. Shohat, MD

Department of Pediatrics B, Beilinson Medical Center, Petah-Tikva, Tel-Aviv University Sackler School of Medicine, Israel

M. Mimouni, MD

Department of Pediatrics B, Beilinson Medical Center, Petah-Tikva, Tel-Aviv University Sackler School of Medicine, Israel

A. Shuper, MD

Department of Pediatrics B, Beilinson Medical Center, Petah-Tikva, Tel-Aviv University Sackler School of Medicine, Israel

I. Varsano, MD

Department of Pediatrics B, Beilinson Medical Center, Petah-Tikva, Tel-Aviv University Sackler School of Medicine, Israel

Fifteen infants with seborrheic dermatitis were treated with topical glucocorticosteroids (flumethasone pivalate 0.02%). Early morning plasma cortisol levels were determined prior to treatment, during the 10-day treatment period, and 2 days after its termination. The mean plasma cortisol level prior to treatment was 8.8 ± 3.4 µg%; after 2 days of application there was a significant decrease of the mean to 2.5 ± 1.3 µg% that persisted throughout the treatment period. Two days after termination of treatment, the mean plasma cortisol level rose to 7.1 ± 3.7 µg% but in five infants was still less than 5 µg% and in two less than 2 µg%, the latter two having shown the greatest involvement of the skin. The possibility of pituitary/adrenocortical inhibition similar to that observed with the systemic administration of glucocorticosteroids and the potential associated risks should be considered when treating cases that would require extensive application of flumethasone pivalate in infants.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?